Literature DB >> 33603735

O-Linked N-Acetylglucosamine Modification of Mitochondrial Antiviral Signaling Protein Regulates Antiviral Signaling by Modulating Its Activity.

Junghwa Seo1,2, Yun Soo Park1,2, Tae Hyun Kweon1,2, Jingu Kang1,2, Seongjin Son1,2, Han Byeol Kim3, Yu Ri Seo3, Min Jueng Kang3, Eugene C Yi1,3, Yong-Ho Lee1,4, Jin-Hong Kim1,5, Boyoun Park1,6, Won Ho Yang1,6, Jin Won Cho1,6.   

Abstract

Post-translational modifications, including O-GlcNAcylation, play fundamental roles in modulating cellular events, including transcription, signal transduction, and immune signaling. Several molecular targets of O-GlcNAcylation associated with pathogen-induced innate immune responses have been identified; however, the direct regulatory mechanisms linking O-GlcNAcylation with antiviral RIG-I-like receptor signaling are not fully understood. In this study, we found that cellular levels of O-GlcNAcylation decline in response to infection with Sendai virus. We identified a heavily O-GlcNAcylated serine-rich region between amino acids 249-257 of the mitochondrial antiviral signaling protein (MAVS); modification at this site disrupts MAVS aggregation and prevents MAVS-mediated activation and signaling. O-GlcNAcylation of the serine-rich region of MAVS also suppresses its interaction with TRAF3; this prevents IRF3 activation and production of interferon-β. Taken together, these results suggest that O-GlcNAcylation of MAVS may be a master regulatory event that promotes host defense against RNA viruses.
Copyright © 2021 Seo, Park, Kweon, Kang, Son, Kim, Seo, Kang, Yi, Lee, Kim, Park, Yang and Cho.

Entities:  

Keywords:  O-linked N-Acetylglucosamine (O-GlcNAc); RIG-I-like receptors signaling; host defense mechanism; innate immunity; mitochondrial antiviral signaling protein

Year:  2021        PMID: 33603735      PMCID: PMC7884448          DOI: 10.3389/fimmu.2020.589259

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  45 in total

Review 1.  O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress.

Authors:  Natasha E Zachara; Gerald W Hart
Journal:  Biochim Biophys Acta       Date:  2004-07-06

2.  Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif.

Authors:  Supriya K Saha; Eric M Pietras; Jeannie Q He; Jason R Kang; Su-Yang Liu; Gagik Oganesyan; Arash Shahangian; Brian Zarnegar; Travis L Shiba; Yao Wang; Genhong Cheng
Journal:  EMBO J       Date:  2006-07-06       Impact factor: 11.598

3.  O-GlcNAc occurs cotranslationally to stabilize nascent polypeptide chains.

Authors:  Yanping Zhu; Ta-Wei Liu; Samy Cecioni; Razieh Eskandari; Wesley F Zandberg; David J Vocadlo
Journal:  Nat Chem Biol       Date:  2015-03-16       Impact factor: 15.040

4.  O-linked GlcNAcylation elevated by HPV E6 mediates viral oncogenesis.

Authors:  Qinghua Zeng; Rui-Xun Zhao; Jianfeng Chen; Yining Li; Xiang-Dong Li; Xiao-Long Liu; Wei-Ming Zhang; Cheng-Shi Quan; Yi-Shu Wang; Ying-Xian Zhai; Jian-Wei Wang; Mariam Youssef; Rutao Cui; Jiyong Liang; Nicholas Genovese; Louise T Chow; Yu-Lin Li; Zhi-Xiang Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-01       Impact factor: 11.205

5.  Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-β-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes.

Authors:  Thomas Gawlowski; Jorge Suarez; Brian Scott; Moises Torres-Gonzalez; Hong Wang; Raphaela Schwappacher; Xuemei Han; John R Yates; Masahiko Hoshijima; Wolfgang Dillmann
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

6.  O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter.

Authors:  Ramona Jochmann; Mathias Thurau; Susan Jung; Christian Hofmann; Elisabeth Naschberger; Elisabeth Kremmer; Thomas Harrer; Matthew Miller; Niels Schaft; Michael Stürzl
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

Review 7.  Regulation of RIG-I Activation by K63-Linked Polyubiquitination.

Authors:  Masaaki Okamoto; Takahisa Kouwaki; Yoshimi Fukushima; Hiroyuki Oshiumi
Journal:  Front Immunol       Date:  2018-01-05       Impact factor: 7.561

8.  Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity.

Authors:  Yuheng Shi; Bofeng Yuan; Wenting Zhu; Rui Zhang; Lin Li; Xiaojing Hao; She Chen; Fajian Hou
Journal:  Nat Commun       Date:  2017-05-04       Impact factor: 14.919

9.  O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit.

Authors:  Mingzuo Jiang; Bing Xu; Xiaowei Li; Yulong Shang; Yi Chu; Weijie Wang; Di Chen; Nan Wu; Sijun Hu; Song Zhang; Mengbin Li; Kaichun Wu; Xiaoyong Yang; Jie Liang; Yongzhan Nie; Daiming Fan
Journal:  Oncogene       Date:  2018-08-09       Impact factor: 9.867

10.  O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease.

Authors:  Nicholas P Marotta; Yu Hsuan Lin; Yuka E Lewis; Mark R Ambroso; Balyn W Zaro; Maxwell T Roth; Don B Arnold; Ralf Langen; Matthew R Pratt
Journal:  Nat Chem       Date:  2015-10-12       Impact factor: 24.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.